|
HDAC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-16 |
| Normal-vs-Stage2 |
1.138050E-03 |
| Normal-vs-Stage3 |
6.76081413075735E-12 |
| Normal-vs-Stage4 |
1.68864922045486E-12 |
| Stage1-vs-Stage2 |
8.365500E-02 |
| Stage1-vs-Stage3 |
8.352400E-01 |
| Stage1-vs-Stage4 |
9.216300E-02 |
| Stage2-vs-Stage3 |
1.082620E-01 |
| Stage2-vs-Stage4 |
8.584100E-03 |
| Stage3-vs-Stage4 |
1.052020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.88098491916389E-15 |
| Normal-vs-AfricanAmerican |
4.73190000005452E-06 |
| Normal-vs-Asian |
7.47569783854374E-11 |
| Caucasian-vs-AfricanAmerican |
5.377200E-01 |
| Caucasian-vs-Asian |
5.663600E-01 |
| AfricanAmerican-vs-Asian |
2.844600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.11026768176725E-12 |
| Normal-vs-Female |
7.7715611723761E-16 |
| Male-vs-Female |
8.013000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(41-60Yrs) |
5.21804821573824E-13 |
| Normal-vs-Age(61-80Yrs) |
2.72960543057366E-11 |
| Normal-vs-Age(81-100Yrs) |
1.550560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.079000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.096600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.796010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.299800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.079400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.462200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.083500E-02 |
| Classical-VS-Follicular |
3.260200E-01 |
| Classical-VS-Other |
9.786000E-02 |
| Classical-VS-Normal |
1.91613391820056E-12 |
| Tall-VS-Follicular |
3.321200E-01 |
| Tall-VS-Other |
4.510000E-01 |
| Tall-VS-Normal |
1.26649801757139E-11 |
| Follicular-VS-Other |
3.294400E-01 |
| Follicular-VS-Normal |
2.68630007127513E-10 |
| Other-VS-Normal |
7.500300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.48414655302076E-12 |
| Normal-vs-N1 |
1.62714286489063E-12 |
| N0-vs-N1 |
9.65059999999962E-05 |
|
|
